Battery-Operated Skin Patch Offers New Option for Migraine Sufferers, NuPathe Inc. Reveals

The first skin patch approved to treat migraines offers patients an alternative to pills, nasal sprays and injections, the U.S. Food and Drug Administration says. The agency approved the Zecuity patch in January 2013 as a treatment for migraines after they begin. The patch contains sumatriptan (brand name Imitrex), a widely prescribed drug for treating migraines, and wraps around the arm or thigh like an ACE bandage.

Back to news